Today’s AI Top Pick: TIGR

9/3/2026 · Reliable Bullish screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · TIGR60%465 resolved forecasts · 45d window · verify →

View the live TIGR price forecast →

Today's pick · Reliable BullishTIGRBUY NOW8.6 / 109/3/2026

TIGR (UP Fintech) is the standout buy today because it combines the most explosive multi-timeframe forecast stack in the pool with a fresh, hard catalyst and dirt-cheap fundamentals. The 4h horizon points to +73.3%/+77.9%/+83.2% short/mid/long, the 1d shows +10.4%/+62.8%/+62.6%, and the 1wk — despite a punishing -33.84% recent drawdown — still forecasts +30.1% mid and +52.4% long. That is the rare structure where near-term momentum and long-tail expected return both stack, not a single-bar outlier. Entry timing is favorable, not stretched. Position in weekly range sits at 15.99% and daily at 28.25% — you are buying in the bottom third of the base after a >30% weekly washout, not chasing. The 4h has already reclaimed 78.9% of range, confirming a short-term turn, so the tape has flipped but the swing structure is nowhere near topped. bullish_prob is 1.0 (kronos), near_term_bullish 0.4, RSI a neutral 45.08 — plenty of runway. Fundamentals are the cheapest in the reliable-bullish cohort: PE 8.09, fwdPE 6.01, PS 1.20, debt/equity 0.07, ROE 13.63%, operating margin 43.97%, profit margin 16.21%, sales YoY +41.46%, EPS next Y +54.18%, analyst recom 1.60, target upside 48%. The recent Q2 2026 earnings call was described as a 'Record Quarter' with 'Record Revenue and Return to profitability' — a genuine positive catalyst dated 8/26. The Insider Monkey 'bigger bill' piece is a mild caveat on cost intensity, not a guidance cut or legal event. Why today vs. wait: the daily and weekly are still deep in their bases (28% and 16% of range), so there is no chase premium; the 4h has already confirmed reversal so you are not catching a falling knife either. The setup is a post-earnings shakeout into a base with the model pricing in a 50%+ recovery over the mid/long horizon. Waiting risks losing the base — the 4h forecast of +73% short is unusually large.

TIGR forecast chart
Entry zone
$4.70–$4.85 (starter today at market ~$4.83; add on any dip toward $4.55)
Stop loss
$4.20 closing basis (below the 21wk low zone; ~13% risk)
First target
$5.60 (fills 4h gap and clears daily mid range, ~+16%)
Longer target
$6.80–$7.30 (aligns with 1d fc_mid/long +62% and 1wk fc_long +52%)
Risks
  • Weekly drawdown of -33.84% signals a broken longer-term trend — a failed reclaim of $4.20 opens the door to sub-$4
  • China-linked broker: HK/China regulatory or FX headline risk can gap the ADR 5–10% overnight regardless of setup
  • Small cap ($830M) with 4.54% short float — thin liquidity amplifies both directions
  • 'Bigger Bill' cost-intensity concerns from Insider Monkey could pressure margins if opex outpaces the revenue ramp
  • 4h already at 78.9% of range — very short-term pullback to $4.55–$4.65 is plausible before the next leg
Honorable mentions
CALXCleanest multi-TF agreement in the pool — 4h fc +44/50/50, 1d +9/34/22, 1wk +2/4/28, all positive. Bottom of range (11% daily, 15% weekly), RSI 43.6, recom 1.22, fwdPE 16.3, PEG 0.46, target upside 65.9%. Lacks a hard catalyst but the tape is unambiguous.
GRABEvery timeframe forecast positive (4h +21/29/50, 1d +1/17/23, 1wk +1/3/3), bottom-third of range on all TFs (14/24/24%), bullish_prob 1.0, recom 1.24, target upside 67.1%. Post-earnings -7% weakness is the pullback, not a broken thesis.
Full ranking (15)
#SymbolVerdictScoreRead
1TIGRBUY NOW8.6Record Q2 + cheapest valuation (fwdPE 6.0) + massive multi-TF forecasts (+73% 4h, +62% 1d, +52% 1wk long) after a 34% weekly washout.
2CALXBUY NOW8.0All-timeframe positive forecasts, near range lows (11% daily), fwdPE 16, PEG 0.46, recom 1.22 — cleanest multi-TF alignment in the pool.
3GRABBUY NOW7.5All TFs positive, low in range on every timeframe, post-earnings dip provides entry; bullish_prob 1.0 and 67% analyst upside.
4AAONBUY PULLBACK7.2Deeply oversold (RSI 29.7, weekly range 0%), 1d fc +26/+30 mid/long, but weekly forecast barely positive — needs base confirmation.
5FUTUBUY PULLBACK6.8Elite fundamentals (ROE 31%, PM 43%, sales +44%) and record Q2, but weekly forecasts all negative (-5/-19/-27) — wait for weekly to firm.
6PINSBUY PULLBACK6.3Weekly fc +26/+62, bottom of daily range (3%), RSI 36 — but CFO departure and slowing revenue is a real overhang.
7ALNYWAIT6.0Strong 4h fc +37/+52/+50 and biotech growth (sales +95%), but sitting at 98.99% of daily range and weekly forecast turns negative — chasing.
8ORCLBUY PULLBACK5.81d fc +14/+30 solid, but 1h/4h/1wk short forecasts all negative and weekly drawdown -34.78% — mixed signals.
9SEWAIT5.51wk fc mostly negative short/mid, PEG 1.22, fwdPE 23.8 — full valuation and weakening momentum.
10ETORWAIT5.3Cheap (PE 11.7, fwdPE 10.4) with KeyBanc initiation, but bullish_prob null, insider $3.12M sale, only two TFs and mixed.
11CLBTWAIT5.0Big 1d fc +34/+34, but recent CEO shift and guidance cuts (per 8/21 headline) and weekly fc negative -10/-18.
12ADMAAVOID4.8Rating downgrade 9/2 + fiduciary duty investigation 9/1 — landmines outweigh cheap valuation despite strong forecasts.
13WAYAVOID4.5At 95%/82%/99% of range on every TF, weekly forecasts all negative, bullish_prob only 0.2 — pure chase.
14ALGTWAIT4.30% of weekly range and -36.98% drawdown — deep value but weekly fc all negative; wait for reversal.
15FIGRAVOID3.8Bullish_prob null, daily fc all negative (-0.9/-2.9/-7.8), no perf_year data — insufficient confirmation.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.